CompaniesByCap
ACRS
Aclaris Therapeutics, Inc. (ACRS)
NASDAQ · Healthcare

Aclaris Therapeutics, Inc. Cash Flow 2017–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015
Operating Activities
Operating Cash Flow-47.1M-20.1M-78.3M-67.6M-52.1M-38.6M-96.4M-100.8M-54.7M-34.6M-20.4M
Depreciation & Amort.454,000807,000863,000797,000923,0001.3M6.4M1.9M402,000120,00090,000
Investing Activities
Capital Expenditure111,000121,0001.3M605,000308,000453,0001.6M1.4M1.2M232,000507,000
Free Cash Flow-47.2M-20.2M-79.6M-68.2M-52.4M-39.1M-98.1M-102.2M-55.9M-34.8M-20.9M
Financing Activities
Dividends Paid
Stock Buybacks

Aclaris Therapeutics, Inc. Cash Flow — FAQ

Aclaris Therapeutics, Inc. (ACRS) cash flow over the last 9 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see ACRS's cash flow history?

The chart and table above show Aclaris Therapeutics, Inc.'s cash flow by year and by quarter, including the growth rate.